Cancer Immunotherapy Using RNA Aptamers for Cell-Selective Delivery or Intracellular Target Inhibition

Time: 11:30 am
day: Conference Day Two

Details:

  • Expanding therapeutic horizons of aptamers beyond conventional targets on cell surface
  • Leveraging innovative oligonucleotide chemistries to enable novel cancer treatment strategies
  • Advancing conjugation technologies to enhance delivery and address complex myeloid cell biology

Speakers: